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A B S T R A C T
Objective. To identify the risk factors that could predict postoperative outcome after aortic valve replacement in
pediatric patients with isolated aortic regurgitation (AR).
Background. There is controversy regarding the appropriate timing of surgery in asymptomatic or minimally
symptomatic patients with isolated AR. In the pediatric age group, there are limited studies in this regard and most
of them are on combined aortic valve stenosis and regurgitation.
Methods. All patients with biventricular physiology and morphologic left ventricle (LV) who underwent aortic valve
surgery for AR from January 1988 to July 2010 were included in the study. Demographic, clinical, and echocardio-
graphic data were collected at presurgical visit, early postoperative, 1 year, and most recent follow-up.
Results. Among 53 patients (36 males), 18 had LV end-diastolic diameter (LVEDD) z-score >4 standard deviation
(SD) (group I) and 35 had LVEDD <4 SD (group II). Forty-one had long-term follow-up. Mean age at surgery was
11.6  5.9 years; mean follow-up was 6.9  5.6 years. Preoperative LVEDD >4 SD predicted persistent LV dilation
(>2 SD) at early post-op (P < .05) and 1 year follow-up (P = .09). Preoperative decreased LV function (fractional
shortening <28%) was the only significant predictor of persistent LV dysfunction at most recent follow-up and
requirement for repeat interventions (P < .01). Most have reduction of LV dimensions in the immediate postopera-
tive period to normal limits.
Conclusion. In children with AR, preoperative LV dysfunction and extreme LV dilation (>4 SD) are significant
predictors of incomplete LV remodeling or persistent LV dysfunction.
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Introduction
Aortic regurgitation (AR) results in volumeoverload and eccentric hypertrophy of the
left ventricle (LV). Over time, chronic aortic
insufficiency leads to LV dilation and dysfunc-
tion.1 Aortic valve replacement has been shown to
improve hemodynamics in children with moderate
to severe AR.2,3 The American Heart Association
has published guidelines for the management
of children with isolated AR. The indication for
surgery is similar to that for adults, that is, New
York Heart Association (NYHA) functional class
III/IV symptoms, LV dysfunction (LV ejection
fraction <50%), or progressive LV enlargement
(end-diastolic dimension >4 standard deviation
(SD) above normal for body surface area and
weight).4
Symptomatic patients need valve replacement
irrespective of LV size.5,6 But there is still contro-
versy regarding the appropriate timing of sur-
gery in asymptomatic or minimally symptomatic
patients.7 If the surgery is delayed until irrever-
sible changes occur, potential benefits may not be
achieved. However, if the surgery is performed
early, it increases the possibility of a later opera-
tion especially in children who will experience
physical growth. Better objective criteria are
needed to predict postoperative LV function and
clinical outcome in these patients to make appro-
priate decision regarding surgical timing.Disclosures: None.
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There have been multiple studies in adults in an
attempt to identify these risk factors,8,9 but most of
the adult patients have other comorbid conditions
including coronary artery disease, diabetes, and
hypertension. In the pediatric age group, there are
limited studies in this regard10 and most of the data
in is on combined aortic valve stenosis and regur-
gitation. There is a paucity of data in the pediatric
age group to determine optimal timing of surgery
in patients with isolated AR.11
Our aim is to identify the risk factors that
could predict postoperative outcome after aortic
valve replacement in pediatric patients.
Methodology
This was a retrospective study conducted at the
Children’s Hospital of Michigan, division of pedi-
atric cardiology. The study was approved by the
institutional review committee at Wayne State
University School of Medicine, Detroit Medical
Center. The inclusion criteria were patients with
biventricular physiology and morphologic LV who
underwent aortic valve surgery for AR from
January 1988 to July 2010 at the Children’s Hos-
pital of Michigan. Exclusion criteria were patients
with any other condition that could lead to volume
or pressure overload on the LV including: (1)
moderate to severe aortic stenosis; (2) moderate
to severe mitral valve regurgitation; (3) moderate
to large ventricular septal defect; (4) moderate or
large patent ductus arteriosus; or (5) unrepaired
coarctation of aorta.
All clinical, surgical, preoperative, and post-
operative echocardiographic data and follow-up
data were reviewed. The demographic and clinical
data collected included patient’s age, gender, eth-
nicity, height, weight, body surface area, and clini-
cal manifestations. Echocardiographic parameters
included left ventricular dimensions, LV function
as measured by shortening fraction, and severity of
AR as measured by the width of the regurgitation
jet, the length of the regurgitation jet, and the
severity of diastolic flow reversal in the descending
aorta. Follow-up echocardiograms at the time of
discharge from hospital, 6–12 months later, and at
most recent follow-up were reviewed. NYHA func-
tional class was determined according to symptoms
and functional impairment at the time of preopera-
tive evaluation regardless of previous symptoms
and history. Surgical data collected included type
of surgery, significant surgical findings, and com-
plications. Operative mortality was defined as
death occurring within the hospitalization period
or within 30 days of operation.
All patients underwent prosthetic aortic valve
replacement or Ross procedure based on the dis-
cretion of the primary cardiologist and the surgeon
performing the procedure. The decisions regard-
ing timing of surgery was made by the primary
cardiologist. The surgeries were performed by four
surgeons over the course of 22 years.
All echocardiograms were performed according
to the American Society of Echocardiography
recommendations. M-mode measurements of left
ventricular dimensions and shortening fraction
were obtained. Z-scores were then calculated using
published normative data.12 In our study, similar to
previous reports, LV end-diastolic dimension 4
SD was considered to be extreme LV dilation.
Patients were then divided into two groups
based on preoperative left ventricular end-diastolic
dimension; group I: patients with severe LV dila-
tion (LV end-diastolic diameter [LVEDD] 4 SD)
and group II: patients without severe LV dilation
(LVEDD <4 SD). In the postoperative period, LV
end-diastolic dimension greater than >2 SD was
considered to represent persistent LV dilation.
Shortening fraction <28% was considered to rep-
resent LV dysfunction.
Statistics
This was a retrospective study. All data were
reported as mean and SD for continuous variables
and frequency for categorical variables. The two
groups were compared using independent samples
t-test, Mann–Whitney U-test, Fisher’s exact, or
chi-square tests depending on the distribution
of the data. Within groups, comparisons of the
changes in LV echocardiographic variables from
preoperative to postoperative measurements were
carried out using one-way analysis of variance for
repeated measurements. All statistical analyses
were performed using SAS software version 9.1
(SAS Institute, Cary, NC, USA). Multivariate
analysis was performed to determine the signifi-
cant variables predicting poor outcome. Statistical
significance was defined as P < .05.
Results
A total of 53 patients underwent aortic valve
replacement from January 1988 to July 2010 for
isolated AR. Of these, 18 were included in group I
and 35 in group II (Table 1). Twenty-eight (53%)
underwent aortic valve replacement (AVR) and 25
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(47%) underwent Ross procedure. Mean age at
surgery was 11.6  5.9 years and mean follow-up
time was 6.9  5.6 years. The demographics are
shown in Table 1. Although majority of patients
were males, the age, weight, and sex distributions
were not significantly different between the groups.
There were more African Americans in group I.
The mean left ventricular end-diastolic and
end-systolic diameters were significantly higher in
group I as expected. Three patients in group II had
LV dysfunction as measured by shortening frac-
tion <28%. While none of the patients had signi-
ficant symptoms, 48% had mild symptoms and
there was no significant difference in number of
patients with symptoms between both groups.
There was no operative mortality in our patients.
Only one patient died 4 years postsurgery due to
non-cardiac-related events. During follow-up, all
patients continued to be predominantly asymp-
tomatic from a cardiac standpoint. Bicuspid aortic
valve was the most common diagnosis as seen in
48% of the patients (Figure 1). Among them, 44%
had balloon valvuloplasty and 21% had surgical
valvotomy performed as primary procedure. Per-
imembranous or supracristal ventricular septal
defect (VSD) leading to aortic insufficiency was
the cause in 17%, truncus arteriosus s/p repair
with truncal valve insufficiency in 13%, rheumatic
fever in 8%, and endocarditis was the etiology in
4% of patients (Table 2).
Outcomes
Severe LV dilation was present in seven (13%)
patients at immediate post-op follow-up and eight
(15%) patients at 1-year follow-up (Figure 2).
Pre-op LV dilation was the only significant predic-
tor of persistent LV dilation (Table 3). Four of the
18 (22%) patients in group I continued to have
persistent LV dilation and four (11%) in group II
developed LV dilation later. Of the four in group
II, two patients had moderate aortic insufficiency
and two developed moderate mitral insufficiency
that led to LV dilation.
Three patients (6%) had LV dysfunction at the
time of pre-op echocardiography and all of them
were in group II. Two of these three patients con-
tinued to have persistent LV dysfunction at the
most recent follow-up, while function improved in
one patient more than a year later after initiation
of inotropes. Another patient with normal pre-op
function developed LV dysfunction at most recent
follow-up. This patient had significant comor-
bidities including developmental delay, kidney
transplant, and development of severe mitral regur-
gitation later that led to significant LV dilation and
dysfunction. This patient was scheduled for mitral
valve replacement.
Repeat procedures were performed in 13 (25%)
patients. Of these, two required aortic valve and
right ventricle (RV) to pulmonary artery (PA)





(n = 35) P Value
Age* 11.4  4.1 11.7  6.8 NS
Weight* 50  31 44  22 NS
Male† 11 (61%) 25 (71%) NS
Caucasian† 11 (61%) 29 (82%) .02
African American† 7 (39%) 3 (9%)
Symptoms† 4 (27%) 13 (38%) NS
Pre-op LVEDD* 6.1  0.9 4.9  0.9 <.01
Pre-op LVESD* 4.1  1.3 1.5  1.8 <.01
Pre-op LVESD >4 SD† 10 (59%) 4 (11%) .001
Pre-op fractional shortening* 38  5 40  8 NS
Pre-op fractional shortening
<28%†
0 (0%) 3 (8%) NS
LVEDV >4 SD† 7 (39%) 10 (28%) NS
AR jet/AV valve width >0.5† 8 (44%) 11 (31%) NS
AR jet up to LV apex† 6 (33%) 13 (37%) NS
Diastolic flow reversal:
severe†
5 (28%) 12 (34%) NS
Follow-up (y)* 8.7  4.5 6.5  5.1 NS
AVR† 10 (56%) 18 (51%) NS
Ross† 8 (44%) 17 (49%)
Prosthesis-aortic valve ratio 0.96  0.06 0.97  0.04 NS
*Mean  SD.
†Number (percentage).





(n = 35) P Value
Bicuspid aortic valve* 7 (40%) 18 (52%) NS
VSD* 3 (18%) 6 (17%) NS
Truncus* 3 (18%) 4 (11%) NS
Rheumatic fever* 2 (12%) 2 (6%) NS
Endocarditis* 1 (6%) 1 (3%) NS
Other* 2 (6%) 4 (11%) NS
*Number (percentage).
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conduit replacement, two required aortic valve
replacement, two required conduit replacement,
three required Melody valve placements, one
required stent placement in an RV-PA conduit, two
required pacemakers for post-op heart block, and
one patient required Amplatzer device closure of
para-aortic-valvular leak. No difference was noted
in the requirement for repeat procedures based on
the type of previous surgery: Ross procedure (24%)
and AVR (25%). There was no significant differ-
ence noted between groups (Figure 3). Pre-op LV
dilation was the only significant predictor of per-
sistent LV dilation at post-op and 1 year follow-up
echocardiogram. Pre-op LV dysfunction was the
only significant predictor of persistent LV dysfunc-
tion and requirement for repeat interventions.
We also evaluated the effect of other echo
parameters on outcomes. The number of patients
with left ventricular end-diastolic volume >4 SD,
ratio of width of regurgitation jet to aortic valve
>0.5, length of regurgitation jet up to LV apex, and
presence of severe holodiastolic flow reversal in
the descending aorta was not significantly differ-
ent between groups. None of these echocardio-
graphic parameters had an impact on outcomes.
Discussion
The appropriate timing for aortic valve replace-
ment has always been controversial in asymp-
tomatic or minimally symptomatic patients with
isolated chronic AR. This is particularly an issue in
pediatric patients as they have growth potential
and earlier surgery increases the chances of requir-
ing a repeat surgery. As demonstrated in prior
studies, our patients had a high rate of subsequent
interventions after surgery for AR.13 Aortic valve
replacement when performed in a timely fashion,
even in children and young adults has been shown
to offer good clinical outcomes and may lead to
normalization of left ventricular size and function
in most patients.11 However, surgery cannot be
delayed too long after which the potential benefits
of surgery are lost and the myocardial injury
cannot be reversed.







Dilation at 1 y
(n = 8)
LV Dysfunction





Extreme LV dilation (LVEDD >4 SD) (n = 18) 5 (28%)* 5 (28%) (P = .09) 0 (0%) 3 (17%)
LV dysfunction (LV SF <28%) (n = 3) 0 (0%) 1 (33%) 2 (67%)** 3 (100%)**
LVESD >4 SD (n = 14) 3 (21%) 4 (28%) 2 (14%) 4 (28%)
Symptoms (n = 17) 1 (6%) 1 (6%) 0 (0%) 2 (12%)
LVEDV >4 SD (n = 17) 1 (6%) 1 (6%) 1 (6%) 4 (23%)
AR jet/AV valve width >0.5 (n = 19) 1 (5%) 1 (5%) 1 (5%) 6 (32%)
AR jet up to LV apex (n = 19) 2 (11%) 2 (11%) 1 (5%) 5 (26%)
Diastolic flow reversal: severe (n = 17) 1 (6%) 2 (12%) 2 (12%) 6 (35%)
*P < .05; **P < .01.
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The findings in our study are similar to previ-
ous studies in that severe left ventricular dilation is
the predictor of persistent left ventricular dilation
after surgery.10 In an adult study by Corti et al.,
a postoperative reduction in end-diastolic dimen-
sion of >20% predicted a significantly better late
survival, and echocardiography within 6 months
postoperatively was able to enable additional risk
stratification, regardless of preoperative findings.14
In our study, in patients in group I, the LV size
improved immediately post-op in most of the
patients to within normal limits with elimination
of volume overload. Our findings are consis-
tent with that of previous studies that severe LV
dilatation is not an isolated abnormality and is
usually associated with larger end-systolic dimen-
sion when compared with patients with smaller
end-diastolic dimension.15
It was shown in previous studies that smaller
indexed LV systolic and diastolic dimensions
were associated with early restoration of LV sys-
tolic function.16 However, in our study, all three
patients with reduced function preoperatively
were in group II, and two of the three continued to
have poor function. In other studies, late increases
in ejection fraction usually occurred in patients
who demonstrated an early significant increase in
function, and late increase in function was unlikely
to occur in patients with no change in ejection
fraction during the first 6 months after opera-
tion.17 Although many patients with preoperative
left ventricular dysfunction experience improved
left ventricular performance after aortic valve
replacement, performance does not always return
to normal.18 In our study, too, all three patients
failed to show any early improvement, and late
improvement was seen in the third patient only
after starting inotropes. Preservation of late ejec-
tion fraction was best if the operation was per-
formed in patients with near-normal preoperative
left ventricular function.9
In chronic AR, symptoms and LV systolic func-
tion were shown to be the main predictors for
postoperative left ventricular dysfunction and
extended long-term outcome after valve replace-
ment.6 In our study, too, LV systolic function was
the main predictor of poor outcomes, including
persistent LV dysfunction and requirement for
repeat procedures. Our study had limited number
of patients with systolic dysfunction pre operatively
and postoperatively, so we could not better analyze
its impact on clinical or echocardiographic out-
comes. However, function continued to be normal
even in patients with severe LV dilation.
Figure 3. There was no significant difference in number of repeat procedures between groups.
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It is known that in the setting of severe AR,
preoperative functional class III or IV symptoms
are independent risk factors for excess immediate
and long-term postoperative mortality. The pres-
ence of class II symptoms is also shown to be a
strong incentive to consider immediate surgical
correction of severe AR.5 In our study, none of the
patients had significant symptoms. The presence
of minimal symptoms however did not have any
effect on persistent left ventricular dilation or
dysfunction.
Our patient population had diagnosis similar to
that expected in an American population with the
majority being bicuspid aortic valve postsurgery or
valvuloplasty.19 Many of our patients had previous
surgical procedures (40% surgical valvotomy,
VSD repair, truncus repair) or catheterization
(21% balloon valvuloplasty) performed. The out-
comes still have been favorable with no surgical
mortality as shown in previous studies where
mechanical AVR had excellent results in patients
after previous repair of congenital heart defects
in childhood, even in combination with complex
concomitant procedures.2
It was shown in previous studies that other echo
parameters can predict severity of AR.20 In our
study, however, echo parameters including the
width and length of the AR jet, severity of diastolic
flow reversal in the descending aorta, and left
ventricular end-diastolic volume did not predict
outcomes.
It has been shown in adults that asymptomatic
patients with normal left ventricular function have
usually a good prognosis with a yearly mortality
rate of approximately 0.04% and they develop left
ventricular dysfunction at a yearly rate of 4%.
Approximately 50% of all patients are asymptom-
atic even after 10 years,21 and LV dysfunction and
dilation may not progress concomitantly as seen in
our study. In such patients with severe AR and
moderate enlargement of the LV, regular check-ups
should be performed to monitor the rate of pro-
gression of LV dilation and dysfunction. Surgery
should be performed if the patient becomes symp-
tomatic or develops deterioration of function.
Surgery should be strongly considered if the LV
z-score increases to greater than 4 SD. Our data
suggest that in patients with normal LV function
and no symptoms can be safely observed if their LV
z-score remains <4 SD.
Stress echocardiography has been shown to be
useful in evaluating pediatric patients after child-
hood Ross surgery for aortic valve disease.22 There
is a role for probably using stress echocardiogra-
phy in detecting the persistent LV remodelling/
dysfunction at follow-up after surgery in further
studies.
Limitations
This was a retrospective study with a limited
number of patients who had poor outcomes, so
findings have to interpreted with caution. These
are patients with diverse diagnoses, and the out-
comes may be affected by the primary diagnosis.
Twenty-two percent of patients were lost to follow-
up. Also, the natural history and late survival
could not be analyzed. Further multicenter pro-
spective studies will be needed to validate these
findings.
Conclusions
In asymptomatic or minimally symptomatic chil-
dren and adolescents with chronic AR, preopera-
tive severe LV dilation (>4 SD) is a significant
predictor of persistent LV dilation (>2 SD). Preop-
erative decreased LV function is the only predictor
of persistent systolic dysfunction and requirement
for repeat interventions. Systolic dysfunction and
LV dilation are independent predictors of out-
comes and they do not necessarily progress con-
comitantly. Most of the patients have reduction of
LV dimensions in the immediate postoperative
period to within normal limits.
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